COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses.
Jenny IversenKeith SabinJudy ChangRuth Morgan ThomasGarrett PrestageSteffanie A StrathdeeLisa MaherPublished in: Journal of the International AIDS Society (2020)
Disruptions to both licit and illicit supply chains, loss of income and livelihoods and changes in behaviour as a result of lockdowns and physical distancing have the potential to exacerbate the impacts of the COVID-19 pandemic on key populations. While these impacts will vary significantly, human-rights approaches to COVID-19 emergency laws and public health prevention measures that are population-specific and sensitive, will be key to reducing adverse health outcomes and ensuring that no one is left behind.
Keyphrases
- public health
- coronavirus disease
- sars cov
- physical activity
- mental health
- endothelial cells
- emergency department
- antiretroviral therapy
- hiv positive
- hiv infected
- hepatitis c virus
- human immunodeficiency virus
- hiv testing
- respiratory syndrome coronavirus
- genetic diversity
- induced pluripotent stem cells
- adverse drug
- electronic health record
- drug induced